Rapid, sensitive recovery of recombinant attenuated Salmonella enterica serovar typhi vaccine strains from human blood

Kathleen R. Lottenbach, Sandra M. Kelly-Aehle, Karen E. Brenneman, Roy Curtiss, Sharon E. Frey

Research output: Contribution to journalArticle

Abstract

Prior to initiating a phase 1 dose escalation trial of the safety and immunogenicity of live, oral, recombinant, attenuated Salmonella enterica serovar Typhi vaccine strains in human subjects, the suitability of conventional blood culture procedures to rapidly and reliably detect the organisms in human blood was investigated. Blood culture specimens, with and without added growth supplements, were inoculated with study organism concentrations ranging from approximately 300 to as few as 1 to 2 CFU/10 ml culture and processed in a Bactec 9240 fluorescent series aerobic blood culture system. All cultures seeded with > 6 CFU and 93% of cultures seeded with ~ 1 to 2 CFU were identified as positive for microbial growth within 44 h of incubation. The results were within the performance standard of ≤ 5 days to detection that is expected for Gram-negative cultures seeded at 10 to 50 CFU/vial. Recovery of test organisms from blood culture was not improved by the addition of supplements, but cultures with added supplements were identified positive an average of 5 h sooner than those without added supplements. Reliable detection of the investigational vaccine strains at < 1 CFU/ml of blood within 2 days in conventional blood culture without added supplements allowed for shortened confinement time of study volunteers without compromising subject safety.

Original languageEnglish (US)
Pages (from-to)1473-1478
Number of pages6
JournalClinical and Vaccine Immunology
Volume20
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Salmonella typhi
Salmonella
Blood
Vaccines
Recovery
Safety
Time and Motion Studies
Growth
Volunteers
Blood Culture

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Rapid, sensitive recovery of recombinant attenuated Salmonella enterica serovar typhi vaccine strains from human blood. / Lottenbach, Kathleen R.; Kelly-Aehle, Sandra M.; Brenneman, Karen E.; Curtiss, Roy; Frey, Sharon E.

In: Clinical and Vaccine Immunology, Vol. 20, No. 9, 09.2013, p. 1473-1478.

Research output: Contribution to journalArticle

Lottenbach, Kathleen R. ; Kelly-Aehle, Sandra M. ; Brenneman, Karen E. ; Curtiss, Roy ; Frey, Sharon E. / Rapid, sensitive recovery of recombinant attenuated Salmonella enterica serovar typhi vaccine strains from human blood. In: Clinical and Vaccine Immunology. 2013 ; Vol. 20, No. 9. pp. 1473-1478.
@article{d41ab1c1a56549f39a743167d15d8027,
title = "Rapid, sensitive recovery of recombinant attenuated Salmonella enterica serovar typhi vaccine strains from human blood",
abstract = "Prior to initiating a phase 1 dose escalation trial of the safety and immunogenicity of live, oral, recombinant, attenuated Salmonella enterica serovar Typhi vaccine strains in human subjects, the suitability of conventional blood culture procedures to rapidly and reliably detect the organisms in human blood was investigated. Blood culture specimens, with and without added growth supplements, were inoculated with study organism concentrations ranging from approximately 300 to as few as 1 to 2 CFU/10 ml culture and processed in a Bactec 9240 fluorescent series aerobic blood culture system. All cultures seeded with > 6 CFU and 93{\%} of cultures seeded with ~ 1 to 2 CFU were identified as positive for microbial growth within 44 h of incubation. The results were within the performance standard of ≤ 5 days to detection that is expected for Gram-negative cultures seeded at 10 to 50 CFU/vial. Recovery of test organisms from blood culture was not improved by the addition of supplements, but cultures with added supplements were identified positive an average of 5 h sooner than those without added supplements. Reliable detection of the investigational vaccine strains at < 1 CFU/ml of blood within 2 days in conventional blood culture without added supplements allowed for shortened confinement time of study volunteers without compromising subject safety.",
author = "Lottenbach, {Kathleen R.} and Kelly-Aehle, {Sandra M.} and Brenneman, {Karen E.} and Roy Curtiss and Frey, {Sharon E.}",
year = "2013",
month = "9",
doi = "10.1128/CVI.00331-13",
language = "English (US)",
volume = "20",
pages = "1473--1478",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Rapid, sensitive recovery of recombinant attenuated Salmonella enterica serovar typhi vaccine strains from human blood

AU - Lottenbach, Kathleen R.

AU - Kelly-Aehle, Sandra M.

AU - Brenneman, Karen E.

AU - Curtiss, Roy

AU - Frey, Sharon E.

PY - 2013/9

Y1 - 2013/9

N2 - Prior to initiating a phase 1 dose escalation trial of the safety and immunogenicity of live, oral, recombinant, attenuated Salmonella enterica serovar Typhi vaccine strains in human subjects, the suitability of conventional blood culture procedures to rapidly and reliably detect the organisms in human blood was investigated. Blood culture specimens, with and without added growth supplements, were inoculated with study organism concentrations ranging from approximately 300 to as few as 1 to 2 CFU/10 ml culture and processed in a Bactec 9240 fluorescent series aerobic blood culture system. All cultures seeded with > 6 CFU and 93% of cultures seeded with ~ 1 to 2 CFU were identified as positive for microbial growth within 44 h of incubation. The results were within the performance standard of ≤ 5 days to detection that is expected for Gram-negative cultures seeded at 10 to 50 CFU/vial. Recovery of test organisms from blood culture was not improved by the addition of supplements, but cultures with added supplements were identified positive an average of 5 h sooner than those without added supplements. Reliable detection of the investigational vaccine strains at < 1 CFU/ml of blood within 2 days in conventional blood culture without added supplements allowed for shortened confinement time of study volunteers without compromising subject safety.

AB - Prior to initiating a phase 1 dose escalation trial of the safety and immunogenicity of live, oral, recombinant, attenuated Salmonella enterica serovar Typhi vaccine strains in human subjects, the suitability of conventional blood culture procedures to rapidly and reliably detect the organisms in human blood was investigated. Blood culture specimens, with and without added growth supplements, were inoculated with study organism concentrations ranging from approximately 300 to as few as 1 to 2 CFU/10 ml culture and processed in a Bactec 9240 fluorescent series aerobic blood culture system. All cultures seeded with > 6 CFU and 93% of cultures seeded with ~ 1 to 2 CFU were identified as positive for microbial growth within 44 h of incubation. The results were within the performance standard of ≤ 5 days to detection that is expected for Gram-negative cultures seeded at 10 to 50 CFU/vial. Recovery of test organisms from blood culture was not improved by the addition of supplements, but cultures with added supplements were identified positive an average of 5 h sooner than those without added supplements. Reliable detection of the investigational vaccine strains at < 1 CFU/ml of blood within 2 days in conventional blood culture without added supplements allowed for shortened confinement time of study volunteers without compromising subject safety.

UR - http://www.scopus.com/inward/record.url?scp=84884697875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884697875&partnerID=8YFLogxK

U2 - 10.1128/CVI.00331-13

DO - 10.1128/CVI.00331-13

M3 - Article

C2 - 23885029

AN - SCOPUS:84884697875

VL - 20

SP - 1473

EP - 1478

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 9

ER -